DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0024623 | Malignant neoplasm of stomach | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C0025286 | Meningioma | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C0152025 | Polyneuropathy | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C0033687 | Proteinuria | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C0003864 | Arthritis | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C0342788 | Renal carnitine transport defect | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C0236733 | Amphetamine-Related Disorders | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C0684249 | Carcinoma of lung | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C1561643 | Chronic Kidney Diseases | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C0553723 | Squamous cell carcinoma of skin | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C0032580 | Adenomatous Polyposis Coli | CD55 | 1604 | CD55 molecule (Cromer blood group) | P08174 |
C1531647 | Cerebral ventriculomegaly | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0027947 | Neutropenia | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0036572 | Seizures | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0027092 | Myopia | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0266483 | Pachygyria | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C3714756 | Intellectual Disability | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0014544 | Epilepsy | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0003504 | Aortic Valve Insufficiency | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0023530 | Leukopenia | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C1332206 | Adult Lymphoma | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0027051 | Myocardial Infarction | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0392788 | Nasal Type Extranodal NK/T-Cell Lymphoma | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0266463 | Lissencephaly | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
C0751495 | Seizures, Focal | TMTC3 | 160418 | transmembrane O-mannosyltransferase targeting cadherins 3 | Q6ZXV5 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024